Senores Pharmaceuticals Limited — Important, 02-05-2025: General Updates
02-05-2025 | 06:51 pm
02-05-2025 | 06:51 pm
Senores Pharmaceuticals’ US subsidiary faces a penalty of about USD 23K plus USD 27.5K interest from the IRS over alleged unpaid tax. The company asserts the tax was already settled and expects no significant financial or operational impact. Discussions with the IRS are ongoing to resolve the matter.
No comments yet. Be the first to comment!
